Dare Bioscience Investor Presentation Deck
no
There are approximately 65 million women in the US Aged 15-44²
12 Million
Current
Non-Users
•Currently use
OvapreneⓇ - Potential Market Opportunity
contraception
•Sexually active
Not seeking
pregnancy
35 Million Women²,3
Potential Candidates
for OvapreneⓇ
11 Million
Current
Hormone-free Product
Users
Condom (6.6M)
Withdrawal (4.0M)
Spermicide/diaphragm
(0.06M)
Rhythm/natural family
planning (0.5M)
12 Million
Current
Hormonal
Product Users
Pill (10.3M)
Injectable (1.5M)
•Vaginal Ring
(1.0M)
•Patch (0.1M)
•Emergency
contraception
(0.03M)
30 Million Women ²,3
Not candidates for
Ovaprene®
Sterilization (10.5M)
Pregnant/postpartum/ seeking
pregnancy (5.6M)
Never had intercourse (8.2M)
Current LARC (IUD or implant) user
(5.4M)
1.Source: CDC National Survey for Family Growth, 2013-2015 dataset, cdc.gov.
2. Market research study conducted in 2019 for Daré Bioscience 24
3. Contraceptive use data applied to 2019 population data from US CensusView entire presentation